Ledger.Open graph →
SEC Form D · filed February 6, 2020

ADARx Pharmaceuticals, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Zhen Li · San Diego, CAExec · DirectorRui Zhu · San Diego, CAExecDaryl Brooks · Grandview, TXExec · DirectorRuwack Trust · GREENSBORO, NCExecJames D. Rippeto, Jr · Houston, TXExec · DirectorGurwinder Singh · Jericho, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗